medigraphic.com

2021, Número 1

<< Anterior Siguiente >>

Rev Clin Esc Med 2021; 11 (1)


Biofilms: ¿enemigos de la cicatrización?

Tinoco CV, Brenes LE

Idioma: Español
Referencias bibliográficas: 51
Paginas:
Archivo PDF: 165.04 Kb.


RESUMEN

Una herida crónica es aquella que presenta un retraso en la cicatrización. Los biofilms constan de comunidades polimicrobianas que se adhieren a una superficie, interviniendo negativamente en el proceso de la cicatrización cronificándola. En este artículo se describe el efecto fisiopatológico que produce el biofilm en la herida provocando un estado inflamatorio prolongado, la alteración de la respuesta inmune, el retraso de la reepitelización y la disminución del desarrollo de tejido de granulación que provocan retardo en la cicatrización normal de la herida


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Singer AJ, Clark RA. Cutaneous woundhealing. N Engl J Med. 1999;341(10):738-46.

  2. Scalise A, Bianchi A, Tartaglione C, BollettaE, Pierangeli M, Torresetti M, et al. Microenvironmentand microbiology of skinwounds: the role of bacterial biofilms and relatedfactors. Semin Vasc Surg. 2015;28(3-4):151-9.

  3. Clinton A, Carter T. ChronicWound Biofilms: Pathogenesis and PotentialTherapies. Lab Med. 2015;46(4):277-84.

  4. Wu YK, Cheng NC, Cheng CM. Biofilmsin Chronic Wounds: Pathogenesisand Diagnosis. Trends Biotechnol. 2018.

  5. Kim PJ, Steinberg JS. Wound care: biofilmand its impact on the latest treatment modalities forulcerations of the diabetic foot. Semin Vasc Surg.

  6. Gurjala AN, Geringer MR, Seth AK, HongSJ, Smeltzer MS, Galiano RD, et al. Developmentof a novel, highly quantitative in vivo model forthe study of biofilm-impaired cutaneous woundhealing. Wound Repair Regen. 2011;19(3):400-10.

  7. Wolcott RD, Rhoads DD, Bennett ME,Wolcott BM, Gogokhia L, Costerton JW, et al.Chronic wounds and the medical biofilm paradigm.J Wound Care. 2010;19(2):45-6, 8-50, 2-3.

  8. Metcalf DG, Bowler PG. Biofilm delayswound healing: A review of the evidence.Burns Trauma. 2013;1(1):5-12.

  9. Percival SL, McCarty SM, Lipsky B. Biofilmsand Wounds: An Overview of the Evidence.Adv Wound Care (New Rochelle). 2015;4(7):373-81.

  10. Martin JM, Zenilman JM, LazarusGS. Molecular microbiology: new dimensionsfor cutaneous biology and wound healing.J Invest Dermatol. 2010;130(1):38-48.

  11. Hurlow J, Bowler PG. Potential implicationsof biofilm in chronic wounds: a case series. J WoundCare. 2012;21(3):109-10, 12, 14 passim.

  12. Wolcott R, Dowd S. The role of biofilms:are we hitting the right target? Plast Reconstr Surg.2011;127 Suppl 1:28s-35s.

  13. Schierle CF, De la Garza M, Mustoe TA,Galiano RD. Staphylococcal biofilms impair woundhealing by delaying reepithelialization in a murinecutaneous wound model. Wound Repair Regen.2009;17(3):354-9.

  14. Percival SL, Suleman L. Slough and biofilm:removal of barriers to wound healing by desloughing.J Wound Care. 2015;24(11):498, 500-3, 6-10.

  15. Percival SL, Hill KE, Williams DW, HooperSJ, Thomas DW, Costerton JW. A review of the scientificevidence for biofilms in wounds. Wound RepairRegen. 2012;20(5):647-57.

  16. Rajpaul K. Biofilm in wound care. Br J CommunityNurs. 2015;Suppl Wound Care:S6, s8, s10-1.

  17. Thomson CH. Biofilms: do they affect woundhealing? Int Wound J. 2011;8(1):63-7.

  18. Black CE, Costerton JW. Current conceptsregarding the effect of wound microbial ecology andbiofilms on wound healing. Surg Clin North Am.2010;90(6):1147-60.

  19. Martin P, Leibovich SJ. Inflammatory cellsduring wound repair: the good, the bad and the ugly.Trends Cell Biol. 2005;15(11):599-607.

  20. Fazli M, Bjarnsholt T, Kirketerp-Moller K,Jorgensen A, Andersen CB, Givskov M, et al. Quantitativeanalysis of the cellular inflammatory responseagainst biofilm bacteria in chronic wounds. WoundRepair Regen. 2011;19(3):387-91.

  21. Leid JG, Willson CJ, Shirtliff ME, HassettDJ, Parsek MR, Jeffers AK. The exopolysaccharidealginate protects Pseudomonas aeruginosa biofilmbacteria from IFN-gamma-mediated macrophage killing.J Immunol. 2005;175(11):7512-8.

  22. Bjarnsholt T, Jensen PO, Burmolle M, HentzerM, Haagensen JA, Hougen HP, et al. Pseudomonasaeruginosa tolerance to tobramycin, hydrogenperoxide and polymorphonuclear leukocytesis quorum-sensing dependent. Microbiology.2005;151(Pt 2):373-83.

  23. Thurlow LR, Hanke ML, Fritz T, Angle A,Aldrich A, Williams SH, et al. Staphylococcus aureusbiofilms prevent macrophage phagocytosisand attenuate inflammation in vivo. J Immunol.2011;186(11):6585-96.

  24. Ashcroft GS, Jeong MJ, Ashworth JJ, HardmanM, Jin W, Moutsopoulos N, et al. Tumor necrosisfactor-alpha (TNF-alpha) is a therapeutic targetfor impaired cutaneous wound healing. Wound RepairRegen. 2012;20(1):38-49.

  25. Xu F, Zhang C, Graves DT. Abnormal cell responsesand role of TNF-alpha in impaired diabeticwound healing. Biomed Res Int. 2013;2013:754802.

  26. Werthen M, Henriksson L, Jensen PO, SternbergC, Givskov M, Bjarnsholt T. An in vitro modelof bacterial infections in wounds and other soft tissues.Apmis. 2010;118(2):156-64.

  27. Hill KE, Malic S, McKee R, Rennison T, HardingKG, Williams DW, et al. An in vitro model ofchronic wound biofilms to test wound dressings andassess antimicrobial susceptibilities. J AntimicrobChemother. 2010;65(6):1195-206.

  28. Dowd SE, Sun Y, Smith E, Kennedy JP, JonesCE, Wolcott R. Effects of biofilm treatments on themulti-species Lubbock chronic wound biofilm model.J Wound Care. 2009;18(12):508, 10-12.

  29. Kirker KR, Secor PR, James GA, Fleckman P,Olerud JE, Stewart PS. Loss of viability and inductionof apoptosis in human keratinocytes exposed to Staphylococcusaureus biofilms in vitro. Wound RepairRegen. 2009;17(5):690-9.

  30. Wolcott RD, Rhoads DD, Dowd SE. Biofilmsand chronic wound inflammation. J Wound Care.2008;17(8):333-41.

  31. Sun Y, Smith E, Wolcott R, Dowd SE. Propagationof anaerobic bacteria within an aerobic multi-species chronic wound biofilm model. J WoundCare. 2009;18(10):426-31.

  32. Stephens P, Wall IB, Wilson MJ, Hill KE, DaviesCE, Hill CM, et al. Anaerobic cocci populatingthe deep tissues of chronic wounds impair cellularwound healing responses in vitro. Br J Dermatol.2003;148(3):456-66.

  33. Akiyama H, Kanzaki H, Tada J, Arata J. Staphylococcus aureus infection on cut wounds in themouse skin: experimental staphylococcal botryomycosis.J Dermatol Sci. 1996;11(3):234-8.

  34. Serralta VW. Lifestyles of Bacteria in Wounds:Presence of Biofilms? . In: Harrison-Balestra C, editor.:Wounds; 2001. p. 29-34.

  35. Davis SC, Ricotti C, Cazzaniga A, Welsh E,Eaglstein WH, Mertz PM. Microscopic and physiologicevidence for biofilm-associated wound colonizationin vivo. Wound Repair Regen. 2008;16(1):23-9.

  36. Roche ED, Renick PJ, Tetens SP, Carson DL.A model for evaluating topical antimicrobial efficacyagainst methicillin-resistant Staphylococcus aureusbiofilms in superficial murine wounds. AntimicrobAgents Chemother. 2012;56(8):4508-10.

  37. Davies DG, Parsek MR, Pearson JP, IglewskiBH, Costerton JW, Greenberg EP. The involvementof cell-to-cell signals in the development of a bacterialbiofilm. Science. 1998;280(5361):295-8.

  38. Rashid MH, Rumbaugh K, Passador L, DaviesDG, Hamood AN, Iglewski BH, et al. Polyphosphatekinase is essential for biofilm development, quorumsensing, and virulence of Pseudomonas aeruginosa.Proc Natl Acad Sci U S A. 2000;97(17):9636-41.

  39. Nakagami G, Morohoshi T, Ikeda T, Ohta Y,Sagara H, Huang L, et al. Contribution of quorumsensing to the virulence of Pseudomonas aeruginosain pressure ulcer infection in rats. Wound Repair Regen.2011;19(2):214-22.

  40. Roche ED, Renick PJ, Tetens SP, RamsaySJ, Daniels EQ, Carson DL. Increasing the presenceof biofilm and healing delay in a porcine modelof MRSA-infected wounds. Wound Repair Regen.2012;20(4):537-43.

  41. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, HastertMC, Griswold JA, et al. Pseudomonas aeruginosaforms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun. 2007;75(8):3715-21.

  42. Zhao G, Usui ML, Underwood RA, Singh PK,James GA, Stewart PS, et al. Time course study of delayedwound healing in a biofilm-challenged diabeticmouse model. Wound Repair Regen. 2012;20(3):342-52.

  43. Watters C, DeLeon K, Trivedi U, Griswold JA,Lyte M, Hampel KJ, et al. Pseudomonas aeruginosabiofilms perturb wound resolution and antibiotic tolerancein diabetic mice. Med Microbiol Immunol.2013;202(2):131-41.

  44. Nguyen KT, Seth AK, Hong SJ, GeringerMR, Xie P, Leung KP, et al. Deficient cytokine expressionand neutrophil oxidative burst contributeto impaired cutaneous wound healing in diabetic,biofilm-containing chronic wounds. Wound RepairRegen. 2013;21(6):833-41.

  45. Seth AK, Geringer MR, Hong SJ, Leung KP,Galiano RD, Mustoe TA. Comparative analysis ofsingle-species and polybacterial wound biofilmsusing a quantitative, in vivo, rabbit ear model. PLoSOne. 2012;7(8):e42897.

  46. Dalton T, Dowd SE, Wolcott RD, Sun Y, WattersC, Griswold JA, et al. An in vivo polymicrobialbiofilm wound infection model to study interspeciesinteractions. PLoS One. 2011;6(11):e27317.

  47. Pastar I, Nusbaum AG, Gil J, Patel SB, ChenJ, Valdes J, et al. Interactions of methicillin resistantStaphylococcus aureus USA300 and Pseudomonasaeruginosa in polymicrobial wound infection. PLoSOne. 2013;8(2):e56846.

  48. James GA, Swogger E, Wolcott R, Pulcini E,Secor P, Sestrich J, et al. Biofilms in chronic wounds.Wound Repair Regen. 2008;16(1):37-44.

  49. Kirketerp-Moller K, Jensen PO, Fazli M,Madsen KG, Pedersen J, Moser C, et al. Distribution,organization, and ecology of bacteria in chronicwounds. J Clin Microbiol. 2008;46(8):2717-22.

  50. Neut D, Tijdens-Creusen EJ, Bulstra SK, vander Mei HC, Busscher HJ. Biofilms in chronic diabeticfoot ulcers--a study of 2 cases. Acta Orthop.2011;82(3):383-5.

  51. Han A, Zenilman JM, Melendez JH, ShirtliffME, Agostinho A, James G, et al. The importance ofa multifaceted approach to characterizing the microbialflora of chronic wounds. Wound Repair Regen.2011;19(5):532-41.




2020     |     www.medigraphic.com